Cell Cryopreservation Market, By Product Type (Cryoprotectant Agents and Equipment), By Application (Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, Research Institutes

Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.

Market Dynamics:

Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2020. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global cell cryopreservation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell cryopreservation market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Nippon Genetics, Miltenyi Biotec, Mediatech, Inc., Genzyme Corporation, BioLifeSolutions, Inc., VWR International, LLC, and BiolifeSolutions, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

• By Product Type
• Cryoprotectant Agents
• Glycerol
• Dimethyl Sulfoxide (DMSO)
• Others
• Equipment
• Incubators
• Liquid Nitrogen Supply Tanks
• Freezers
• Others
• By Application
• Stem Cells
• Oocytes and Embryotic cells
• Sperm Cells
• Hepatocytes
• Others
• By End User
• Biopharmaceutical & Pharmaceutical Companies
• Research Institutes
• Biobanks
• IVF clinics
• Others
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Company Profiles:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• GE Healthcare
• Lonza Group Ltd.
• STEMCELL Technologies Inc.
• BioLife Solutions, Inc.
• Cryolife, Inc.
• Organ Recovery Systems Inc.
• Custom Biogenic Systems
• Sartorius AG
• Takara Bio Inc.
• Chart Industries, Inc.
• Biocision, LLC
• Cardinal Health, Inc.
• Helmer Scientific